Deletion of the Androgen Receptor in Adipose Tissue in Male Mice Elevates Retinol Binding Protein 4 and Reveals Independent Effects on Visceral Fat Mass and on Glucose Homeostasis
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Testosterone deficiency is epidemic in obese ageing males with type 2 diabetes, but the direction of causality remains unclear. Testosterone-deficient males and global androgen receptor (AR) knockout mice are insulin resistant with increased fat, but it is unclear whether AR signaling in adipose tissue mediates body fat redistribution and alters glucose homoeostasis. To investigate this, mice with selective knockdown of AR in adipocytes (fARKO) were generated. Male fARKO mice on normal diet had reduced perigonadal fat but were hyperinsulinemic and by age 12 months, were insulin deficient in the absence of obesity. On high-fat diet, fARKO mice had impaired compensatory insulin secretion and hyperglycemia, with increased susceptibility to visceral obesity. Adipokine screening in fARKO mice revealed a selective increase in plasma and intra-adipose retinol binding protein 4 (RBP4) that preceded obesity. AR activation in murine 3T3 adipocytes downregulated RBP4 mRNA. We conclude that AR signaling in adipocytes not only protects against high-fat diet–induced visceral obesity but also regulates insulin action and glucose homeostasis, independently of adiposity. Androgen deficiency in adipocytes in mice resembles human type 2 diabetes, with early insulin resistance and evolving insulin deficiency.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319
Hotta, K., Funahashi, T., Bodkin, N. L., Ortmeyer, H. K., Arita, Y., Hansen, B. C., & Matsuzawa, Y. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1126 · Cited by 1,072
Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791 · cited 1×
“Furthermore, testosterone replacement therapy improves glycemic control in hypogonadal men with type 2 diabetes (4).”
BackgroundAssociation of Specific Symptoms and Metabolic Risks with Serum Testosterone in Older Men
Zitzmann, M., Faber, S., & Nieschlag, E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0401 · Cited by 552
Singh, R., Artaza, J. N., Taylor, W. E., Braga, M., Yuan, X., Gonzalez-Cadavid, N. F., & Bhasin, S. (2006) · Endocrinology · doi:10.1210/en.2004-1649 · Cited by 369
Androgens, insulin resistance and vascular disease in men
Kapoor, D., Malkin, C. J., Channer, K. S., & Jones, T. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02299.x · Cited by 317
Barrett-Connor, E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-807 · Cited by 281
Fan, W., Yanase, T., Nomura, M., Okabe, T., Goto, K., Sato, T., Kawano, H., Kato, S., & Nawata, H. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1000 · Cited by 269
Movérare‐Skrtic, S., Venken, K., Andersson, N., Lindberg, M. K., Svensson, J., Swanson, C., Vanderschueren, D., Oscarsson, J., Gustafsson, J., & Ohlsson, C. (2006) · Obesity · doi:10.1038/oby.2006.75 · Cited by 111 · cited 1×
“ARs are present in adipose tissue, at a higher level in visceral fat than other adipose depots (7), and AR activation affects adipocyte differentiation (8) and lipid metabolism (9).”
BackgroundTestosterone and type 2 diabetes
Grossmann, M., Gianatti, E. J., & Zajac, J. D. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833919cf · Cited by 108
Research works printed but not linked: 34
- Hamilton, 2011, Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy, Clin Endocrinol (Oxf), 74, 377, 10.1111/j.1365-2265.2010.03942.x · DOI · Paper page
- Jones, 2010, Testosterone deficiency: a risk factor for cardiovascular disease?, Trends Endocrinol Metab, 21, 496, 10.1016/j.tem.2010.03.002 · DOI · Paper page
- Joyner, 2002, Intrinsic regional differences in androgen receptors and dihydrotestosterone metabolism in human preadipocytes, Horm Metab Res, 34, 223, 10.1055/s-2002-32144 · DOI · Paper page
- Sato, 2003, Late onset of obesity in male androgen receptor-deficient (AR KO) mice, Biochem Biophys Res Commun, 300, 167, 10.1016/S0006-291X(02)02774-2 · DOI · Paper page
- Yu, 2008, Hyperleptinemia without obesity in male mice lacking androgen receptor in adipose tissue, Endocrinology, 149, 2361, 10.1210/en.2007-0516 · DOI · Paper page
- Lin, 2008, Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor, Hepatology, 47, 1924, 10.1002/hep.22252 · DOI · Paper page
- Eguchi, 2011, Transcriptional control of adipose lipid handling by IRF4, Cell Metab, 13, 249, 10.1016/j.cmet.2011.02.005 · DOI · Paper page
- De Gendt, 2004, A Sertoli cell-selective knockout of the androgen receptor causes spermatogenic arrest in meiosis, Proc Natl Acad Sci U S A, 101, 1327, 10.1073/pnas.0308114100 · DOI · Paper page
- Welsh, 2009, Androgen action via testicular peritubular myoid cells is essential for male fertility, FASEB J, 23, 4218, 10.1096/fj.09-138347 · DOI · Paper page
- Morton, 2001, Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice, J Biol Chem, 276, 41293, 10.1074/jbc.M103676200 · DOI · Paper page
- Winzell, 2004, The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes, Diabetes, 53, S215, 10.2337/diabetes.53.suppl_3.S215 · DOI · Paper page
- Corker, 1978, A radioimmunoassay for testosterone in various biological fluids without chromatography, J Steroid Biochem, 9, 373, 10.1016/0022-4731(78)90634-9 · DOI · Paper page
- De Sousa Peixoto, 2008, Preadipocyte 11beta-hydroxysteroid dehydrogenase type 1 is a keto-reductase and contributes to diet-induced visceral obesity in vivo, Endocrinology, 149, 1861, 10.1210/en.2007-1028 · DOI
- McInnes, 2006, Regulation of adenosine 5′,monophosphate-activated protein kinase and lipogenesis by androgens contributes to visceral obesity in an estrogen-deficient state, Endocrinology, 147, 5907, 10.1210/en.2006-0879 · DOI · Paper page
- Bojesen, 2006, The metabolic syndrome is frequent in Klinefelter’s syndrome and is associated with abdominal obesity and hypogonadism, Diabetes Care, 29, 1591, 10.2337/dc06-0145 · DOI · Paper page
- Basaria, 2006, Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy, Cancer, 106, 581, 10.1002/cncr.21642 · DOI · Paper page
- Zitzmann, 2003, The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men, Diabetologia, 46, 31, 10.1007/s00125-002-0980-9 · DOI · Paper page
- Lin, 2005, Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor, Diabetes, 54, 1717, 10.2337/diabetes.54.6.1717 · DOI · Paper page
- Kobayashi, 2005, Adipokines: therapeutic targets for metabolic syndrome, Curr Drug Targets, 6, 525, 10.2174/1389450054021972 · DOI · Paper page
- Yatagai, 2003, Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus, Metabolism, 52, 1274, 10.1016/S0026-0495(03)00195-1 · DOI · Paper page
- Hu, 1996, AdipoQ is a novel adipose-specific gene dysregulated in obesity, J Biol Chem, 271, 10697, 10.1074/jbc.271.18.10697 · DOI · Paper page
- Blüher, 2002, Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance, Dev Cell, 3, 25, 10.1016/S1534-5807(02)00199-5 · DOI · Paper page
- Semple, 2006, Elevated plasma adiponectin in humans with genetically defective insulin receptors, J Clin Endocrinol Metab, 91, 3219, 10.1210/jc.2006-0166 · DOI
- Lanfranco, 2004, Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy, Clin Endocrinol (Oxf), 60, 500, 10.1111/j.1365-2265.2004.02007.x · DOI · Paper page
- Graham, 2005, Serum retinol binding protein (RBP4) is a novel adipocyte-secreted protein elevated in obesity and type 2 diabetes that contributes to insulin resistance, Diabetes, 54, A5
- Cho, 2006, Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes, Diabetes Care, 29, 2457, 10.2337/dc06-0360 · DOI · Paper page
- Klöting, 2007, Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass, Cell Metab, 6, 79, 10.1016/j.cmet.2007.06.002 · DOI · Paper page
- Graham, 2007, Serum retinal binding protein (RBP4) levels predict intraabdominal fat mass, Diabetes, 56, A365
- Tan, 2007, Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids, J Clin Endocrinol Metab, 92, 2764, 10.1210/jc.2007-0091 · DOI · Paper page
- Ost, 2007, Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes, FASEB J, 21, 3696, 10.1096/fj.07-8173com · DOI · Paper page
- Danielsson, 2005, Insulin resistance in human adipocytes occurs downstream of IRS1 after surgical cell isolation but at the level of phosphorylation of IRS1 in type 2 diabetes, FEBS J, 272, 141, 10.1111/j.1432-1033.2004.04396.x · DOI
- Wu, 2009, RBP4 variants are significantly associated with plasma RBP4 levels and hypertriglyceridemia risk in Chinese Hans, J Lipid Res, 50, 1479, 10.1194/jlr.P900014-JLR200 · DOI · Paper page
- Takebayashi, 2007, Retinol binding protein-4 levels and clinical features of type 2 diabetes patients, J Clin Endocrinol Metab, 92, 2712, 10.1210/jc.2006-1249 · DOI · Paper page
- Lee, 2007, Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents, Metabolism, 56, 327, 10.1016/j.metabol.2006.10.011 · DOI
Cited by
Estrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Testosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 577
Kelly, D. M., & Jones, T. H. (2015) · Obesity Reviews · doi:10.1111/obr.12282 · Cited by 487
Sex Steroid Actions in Male Bone
Vanderschueren, D., Laurent, M. R., Claessens, F., Gielen, E., Lagerquist, M. K., Vandenput, L., Börjesson, A. E., & Ohlsson, C. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1024 · Cited by 327
Lowered testosterone in male obesity: Mechanisms, morbidity and management
Grossmann, M., Tang Fui, M., & Dupuis, P. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.122365 · Cited by 293
Metadata
- Authors
- McInnes, K. J., Smith, L. B., Hunger, N. I., Saunders, P. T. K., Andrew, R., & Walker, B. R.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-04-13
- Volume
- 61
- Issue
- 5
- Pages
- 1072-1081
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2111061353
- Cited by
- 121
- References
- 11
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.